{
    "medicine_id": "a3a1b60000c89cfe503d7952b9349e7d16a566a4",
    "platform_id": "DB13848",
    "metadata": {
        "name": "Fluorodopa F18 8 33 mCi 1mL Injection",
        "composition": "8 33 mCi 1mL Fluorodopa 18F",
        "clinical_particulars": {
            "therapeutic_indications": "Fluorodopa F 18 is indicated for use with positron emission tomography PET to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes PS L12849",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00190",
                        "description": "The bioavailability of Fluorodopa 18F can be increased when combined with Carbidopa"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The bioavailability of Fluorodopa 18F can be increased when combined with Methyldopa"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "The bioavailability of Fluorodopa 18F can be increased when combined with Benserazide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}